Therefore, the aim of this study was to explore the clinicopathological role of CXCR4 and SDF-1 with respect to the tumor immune microenvironment in differentiated thyroid carcinoma on a protein and RNA level. Here, CXCL12 is linked to differentiated thyroid carcinoma.